‘Overall, #antiplatelet monotherapy is ineffective for #stroke prevention [for #AtrialFibrillation] & potentially harmful (especially #elderly), whereas #DAPT associated with bleeding risk similar to OAC. Hence, antiplatelets should not be used for #stroke prevention in #AF’
2020 ESC Guidelines for the diagnosis and management of #AtrialFibrillation #ESCCongress : academic.oup.com/eurheartj/adva…
‘Between 2009 & 2018, in #England, the use of #OAC for #stroke prophylaxis in #AtrialFibrillation increased, with #DOAC accounting for over half of OAC uptake in 2018.’
‘Despite a reduction in the OAC-prescription gap, a new paradox exists relating to #DOAC prescription for the #elderly & those at higher risk of #stroke.’
Temporal trends in #stroke prophylaxis for #AtrialFibrillation
Temporal trends in #DOAC prescription for #stroke prophylaxis in #AtrialFibrillation, by age. #elderly
Prescription of oral #anticoagulants & #antiplatelets for #stroke prophylaxis in #AtrialFibrillation : nationwide time series ecological analysis @ESC_Journals academic.oup.com/europace/advan…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.